Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-031478
Filing Date
2014-05-15
Accepted
2014-05-15 21:59:16
Documents
1
Period of Report
2014-05-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v378925_4.html 4  
1 OWNERSHIP DOCUMENT v378925_4.xml 4 4496
  Complete submission text file 0001144204-14-031478.txt   6246
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019
Business Address
Kazam Joshua A (Reporting) CIK: 0001221355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 14849686